Blar i NTNU Open på forfatter "Abrahamsen, Bo"

Viser treff 1-3 av 3

    • Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway 

      Hoff, Mari; Skurtveit, Svetlana; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Skovlund, Eva; Abrahamsen, Bo; Forsmo, Siri; Schei, Berit (Journal article; Peer reviewed, 2018)
      Summary Use of anti-osteoporotic drugs (AODs) was examined in a Norwegian population 50–85 years. Among them with Fracture Risk Assessment Tool (FRAX) score for major osteoporotic fracture ≥ 20, 25% of the women and 17% ...

    • Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway 

      Hoff, Mari; Skovlund, Eva; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Holvik, Kristin; Abrahamsen, Bo; Schei, Berit (Peer reviewed; Journal article, 2021)
      Summary Bisphosphonates reduce fractures in randomized controlled trials (RCT); however, there is less information from real life. In our population including 14,990 women and 13,239 men, use of bisphosphonates reduced ...

    • Proton pump inhibitors and fracture risk. The HUNT study, Norway. 

      Hoff, Mari; Skovlund, Eva; Skurtveit, Svetlana; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Forsmo, Siri; Abrahamsen, Bo; Schei, Berit (Journal article; Peer reviewed, 2019)
      Summary Proton pump inhibitors (PPIs) have been linked to increased risk of fracture; the data have, however, been diverging. We did not find any increased risk of fractures among users of PPIs in a Norwegian population ...